IRIDEX ANNOUNCES RETIREMENT OF VP FINANCE
IRIDEX Corporation (IRIX)
Last iridex corporation earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=112360&p=irol-irhome
Company Research
Source: GlobeNewswire
MOUNTAIN VIEW, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Romeo Dizon has retired from his position as Vice President of Finance, effective March 27, 2020. Mr. Dizon has agreed to continue to serve as needed as a consultant to facilitate a smooth transition and to provide additional support through the end the Company’s first quarter 2020 reporting cycle. IRIDEX’s Board of Directors has appointed James Mackaness to serve as interim Chief Financial Officer while it searches for a successor to Mr. Dizon. Mr. Mackaness previously served as IRIDEX’s Chief Operating Officer from August 2012 to August 2015 and as the Company’s Chief Financial Officer from January 2008 to August 2012. He is currently a partner with FLG Partners, a leading Silicon Valley CFO services and board advisory consultancy firm, and also curre
Show less
Read more
Impact Snapshot
Event Time:
IRIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRIX alerts
High impacting IRIDEX Corporation news events
Weekly update
A roundup of the hottest topics
IRIX
News
- IRIDEX Co. (NASDAQ: IRIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma ManagementGlobeNewswire
- Ophthalmic Lasers Market, Competitive Landscape and Market Forecasts to 2030 [Yahoo! Finance]Yahoo! Finance
- IRIDEX Co. (NASDAQ: IRIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- IRIDEX Co. (NASDAQ: IRIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
IRIX
Earnings
- 8/8/24 - Miss
IRIX
Sec Filings
- 11/26/24 - Form 8-K
- 11/26/24 - Form 8-K/A
- 11/13/24 - Form 8-K
- IRIX's page on the SEC website